FALCON
Start date:November 2020 Main trial site:
Royal Infirmary of Edinburgh
FALCON is a multi-centre diagnostic study that aims to test the accuracy of a COVID viral detection test that hopes to lead to the development of a point-of-care diagnostic device.
Patients give two sets of samples, one swab and one swab and a saliva samples. One of these samples sets is sent for the testing via the current standard, PCR, and the other is tested using mass spectrometry.
Research Team
Caroline Blackstock
AMU Senior Research Nurse
More EMERGE Trials
ATTEST2 Trial
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)